Association Between Follow-Up Mean Blood Pressure and Blood Pressure Control: A Meta-Regression Analysis of 101 Randomized Trials.

HypertensionAug 17, 2026 (epub)

Abdul Salam, Rupasvi Dhurjati, Rashmi Pant et al.

✦ AI-curated · Sources linked

In 30 seconds

This meta-regression analysis examined the relationship between mean blood pressure (BP) and BP control in 101 randomized trials involving over 85,000 participants. The study found that a mean systolic BP (SBP) of 125 mm Hg was associated with approximately 80% achieving BP control, indicating that lower SBP correlates with better control rates.

Key findings

  • Mean SBP of 120, 125, 130, and 135 mm Hg corresponded to BP control in 85%, 75%, 65%, and 55% of participants in individual RCTs.
  • Each 1 mm Hg reduction in mean SBP was associated with approximately a 2% increase in BP control.
  • An SBP below 125 mm Hg was linked to achieving BP control in approximately 80% of patients.

Why it matters

Understanding the relationship between mean BP and control rates is crucial for clinicians to optimize hypertension management and improve patient outcomes. These findings can help inform treatment strategies and guideline recommendations.

Source

Published in Hypertension. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.